Announcements Trials
Browse Landscape

Status

Completed 11Unknown 3Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 9Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1

Interventions

Blood Specimen Collection 121Surveys and Questionnaires 83Observation 50Radiotherapy 40Drug Therapy 35Surgical Procedures, Operative 34Biopsy 31Specimen Handling 28Data Collection 28Watchful Waiting 21Interviews as Topic 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 18Liquid Biopsy 16Immunotherapy 15Magnetic Resonance Spectroscopy 14Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Neoadjuvant Therapy 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Erlotinib Hydrochloride × Clear all
NCT05525858 2025-04-27

KOSMOSII

Seoul National University Bundang Hospital

Recruiting
1,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03192501 2024-06-25

iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

Second Affiliated Hospital of Guangzhou Medical University

Recruiting
250 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡